| | |
N
|
%
|
|---|
|
Age
|
Median
|
50 (range, 40 – 70)
| |
|
Gender
|
Male
|
28
|
80
|
| |
Female
|
7
|
20
|
|
ECOG
|
1
|
18
|
51.4
|
| |
2
|
17
|
48.6
|
|
Etiology
|
Hepatitis B virus
|
27
|
77.1
|
| |
Hepatitis C virus
|
3
|
8.6
|
| |
Alcoholic
|
2
|
5.7
|
| |
Other
|
3
|
8.6
|
|
Child-Pugh classification
|
A
|
28
|
80
|
| |
B
|
7
|
20
|
|
JIS score
|
2
|
26
|
74.3
|
| |
3
|
9
|
25.7
|
|
Pretreatment AFP (ng/ml)
|
≤ 20
|
10
|
28.6
|
| |
> 20
|
25
|
71.4
|
|
Type of HCC
|
Nodular
|
20
|
57.1
|
| |
Diffuse infiltrative
|
15
|
42.9
|
|
Multiplicity
|
Solitary
|
24
|
68.6
|
| |
Multiple
|
11
|
31.4
|
|
Location of thrombi
|
PV branch
|
17
|
48.6
|
| |
Main portal trunk
|
18
|
51.4
|
|
Previous treatment
|
TACE
|
30
|
85.7
|
| |
PEI and HIFU
|
1
|
2.9
|
| |
None
|
4
|
11.4
|
- Abbreviations: ECOG, Eastern Cooperative Oncology Group; JIS, Japan integrated staging; AFP, α-fetoprotein; HCC, Hepatocellular carcinoma; PV, Portal vein; TACE, Transarterial chemoembolization; PEI, Percutaneous ethanol injection; HIFU, High intensity focused ultrasound.
